Form 4 Filing for Medicus Pharma Ltd.

This filing details a Form 4 filed by Andrew Alasdair Smith, Chief Operating Officer of Medicus Pharma Ltd. On September 4, 2026, Smith acquired 735,294 common shares at a price of $0.1705 per share, bringing his total to 735,458 shares. Concurrently, he was granted an option to purchase 125,000 common shares at an exercise price of $0.1705, with the option vesting quarterly over one year and expiring on September 4, 2031. The option was granted on September 4, 2026. This transaction is subject to Section 16 reporting requirements.